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Abstract: While periodic limb movement disorder (PLMD) in some studies has been linked with a range of negative con-
sequences, others have questioned the validity of the diagnosis. The aim of the present study was to investigate the clinical 
significance of co-morbid PLMD in terms of daytime impairment in insomnia patients when defined in accordance with 
the new diagnostic criteria. 64 older adults complaining of insomnia (mean age = 61.9) were included in the study, and as-
sessed with polysomnography, a sleep diary, the Epworth Sleepiness Scale, and a computerized vigilance test. In all, 28 
patients had a PLM-index above 15 on at least one polysomnography registration; while the remaining 36 participants 
served as comparison group (comprising insomniacs patients without co-morbid PLMD). Adjusting for the potential con-
founding effects of demographics, apnea/hypopneas and symptoms of restless legs syndrome (RLS), we found no signifi-
cant associations between PLMD and daytime sleepiness (measured with both subjective and objective measures). These 
findings illustrate that daytime symptoms of insomnia and PLMD may be difficult to distinguish, thus supporting the no-
tion that the clinical significance of PLMD may be questionable.  
INTRODUCTION 
 Alongside its daytime parallel, restless legs syndrome 
(RLS), periodic limb movement disorder (PLMD) has been 
linked to a range of negative consequences, including re-
duced quality of life, work performance, and impaired social 
and family life [1]. Clinically characterized by repetitive 
stereotypic leg movements, patients with PLMD typically 
experience frequent awakenings and loss of deep sleep, 
which are believed to results in daytime somnolence [2]. The 
prevalence rates of PLMD increase significantly with age 
[3]; while epidemiological studies indicate that 4-11 % 
among the general population suffer from PLMD [4], studies 
on persons above 65 years have shown that between 11 and 
25 % meet the diagnostic criteria [5]. 
 According to the latest edition of the International Classi-
fication of Sleep Disorders [6], the diagnosis of periodic 
limb movements during sleep (PLMS) is defined as episodes 
of 4 or more limb movements each lasting 0.5 to 5 seconds 
with amplitudes greater or equal to 25 % of toe dorsiflexion 
during calibration that occur within 5-90 seconds intervals 
[6]. If polysomnographic data exceed 15+ such events per 
hour on average, and the patient also complain of daytime 
impairment, a diagnosis of PLMD is warranted.  
 The fact that many patients are unaware of their limb 
movements has led to the assumption that PLMS in many 
cases may be an underlying cause of a complaint of insom-
nia. Others have argued that PLMS should be regarded as a  
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normal phenomenon of old age due to their high frequency 
[7]. As such, some regard PLMS as clinically insignificant 
unless they are associated with polyomnographic arousals [8, 
9]. In terms of the PLMD-diagnosis, studies examining the 
association between this condition and other sleep variables 
[10-15] or daytime functioning yield mixed results [12, 15, 
16], thus leaving the clinical significance of PLMD in ques-
tion [10-15, 17, 18].  
 To the best of our knowledge, no studies have examined 
how PLMD, defined in accordance with the latest diagnostic 
criteria, is related to daytime impairment [6]. Also, more 
knowledge is also needed about to what extent PLMD con-
tributes to daytime impairment in insomnia patients. The 
present study was therefore designed to compare patients 
with chronic insomnia with and without a co-morbid diagno-
sis of PLMD, on daytime impairment measured both subjec-
tively and objectively.  
METHODS 
Participants and Procedure  
 Participants were recruited through newspaper adver-
tisements to a randomized, controlled study of treatment of 
insomnia [19]; no additional information about the study 
hypothesis or type of interventions was provided. Inclusion 
criteria were (1) age 55 years or older, (2) fulfillment of the 
DSM-IV criteria for insomnia, including difficulties initiat-
ing sleep, maintaining sleep, and/or early morning awaken-
ings with no ability of return to sleep, (3) duration of at least 
3 months, and (4) complaints of impaired daytime function-
ing. The following exclusion criteria were used: (1) use of 
hypnotic medication the last 4 weeks before project start, (2) 
use of antidepressive or antipsychotic medications, (3) signs 
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of dementia or other serious cognitive impairment defined by 
a score under 23 on the Mini-Mental State Examination [20], 
(4) presence of a major depressive disorder or other severe 
mental disorder as identified by a clinical assessment based 
on The Structured Clinical Interview for DSM-IV (SCID-I) 
[21], (5) working night shifts and being unable or unwilling 
to discontinue this work pattern, (6) unwillingness or inabil-
ity to stop taking sleep medication before start, or (7) having 
a serious somatic condition preventing further participation.  
 In all, 64 participants (mean age = 61.9 years; sd = 6.0) 
fulfilled the criteria for participating in the present study, of 
which 29 were women. Included participants were provided 
with a sleep survey booklet comprising the Epworth Sleepi-
ness Scale [22] and a sleep diary to be completed every 
morning for 2 weeks [23]. Within this two-week period par-
ticipants also completed a computerized test of vigilance 
[24], as well as two nights of polysomnographic monitoring. 
Two sub-samples were distinguished in accordance with the 
diagnostic cut-off for PLMD according to the International 
Classification of Sleep Disorders, second edition [6]. Based 
on the rationale that PLMS show high night-to night vari-
ability [6] and that it is currently recommended to use 
polysomnography for more than one night in order to make a 
proper diagnosis [25], we included patients with PLMI > 15 
on at least one of the two registration nights. In all, 28 par-
ticipants had PLMI above 15 on at least one of the two 
nights (the PLMD group), while the remaining 36 partici-
pants had PLMI equal to or below 15 on both registration 
nights. Of the total sample, 64.5 % used medication regularly 
on a daily or weekly basis while the study took place. The 
most commonly used medication types were antihyperten-
sives (23.4%), antithrombotics (10.9%), and anticholesterols 
(10.9%). None of the participants had used hypnotics during 
the last four weeks. 
Ethics 
 The treatment study from which the current data are col-
lected, was approved by the National Data Inspectorate, the 
Norwegian Medicines Agency, and The Regional Committee 
for Medical Research Ethics in Western Norway. Written 
informed consent was obtained from all participants. Partici-
pants received no payment to participate in the study, and 
they were informed that they could withdraw from the study 
at any time without stating the reason. 
Instruments 
Polysomnography 
 Sleep variables were assessed by ambulant clinical 
polysomnography. All electro-physiologic signals were ac-
quired using Embla A10 (Flaga-Medcare Somnologica ® 3.2 
software package). Data collected during the polysomnogra-
phy registration included recordings from electroencephalo-
gram, electromyogram, and elctroocculogram. In addition, 
respiration flow and limb movements of anterior tibialis 
were recorded, as well as pulse, oximetry and electro-
cardiogram, body position, and snoring. Sleep stages were 
scored independently by two trained polysomnography scor-
ers in 30 seconds epochs according to Rechtshaffen and Ka-
les’ manual [26]. PLMS was defined as episodes of 4 or 
more limb movements each lasting 0.5 to 5 seconds that oc-
cured with 5-90 seconds intervals and with amplitudes 
greater or equal to 25 % of toe dorsiflexion during calibra-
tion, as outlined in the second edition of the International 
Classification of Sleep Disorders [6]. The criteria for ap-
nea/hypopnea were defined as: Duration of 10 seconds, a 
minimum of 50 % in reduction of air flow at the nose and 
mouth, and a fall in oxygen saturation of at least 3 % or an 
arousal in the electroencephalogram of more than 3 seconds. 
PLMI and apnea/hypopnea index (AHI) were calculated for 
each subject, thus representing the individual’s number of 
periodic limb movement events per hour and number of ap-
neas/hypopneas per hour. In line with common scoring crite-
ria [27], limb movements caused by apnea or hypopnea were 
not scored as PLMS. 
Sleep Disorders Questionnaire 
 Symptoms of RLS were assessed by the Sleep Disorders 
Questionnaire [28]. The questionnaire consists of a number 
of statements relevant to sleep, and for each statement the 
participants rate to which degree it applies to them on a 5-
point scale where 1 indicates “never” and 5 “always”. A 
RLS-index was calculated based on the mean of two items 
assessing symptoms of RLS (sensations of itchiness or irrita-
bility in the legs, and difficulties keeping the legs still).  
Sleep Diaries 
 Participants completed sleep diaries every morning for 
two weeks [23], in which one item assessed reported daytime 
sleepiness on a 5-point scale. The mean rating across the two 
weeks were used in the current study. 
Epworth Sleepiness Scale 
 The Epworth Sleepiness Scale [22] is an 8-item self-
report questionnaire designed to assess subjective sleepiness. 
The patients report on a 4-point scale to what extent they are 
likely to fall asleep or doze off in different situations. The 
Cronbach’s alpha coefficient was 0.84 in the current sample. 
Vigilance (Vigil, 5.0) 
 Vigil, test version S1- Quatember-Maly [24], is a 25-
minute computerized test which registers enduring attention 
in a situation with few stimuli changes. The subjects are 
instructed to watch a brightly flashing dot that travels along a 
circular path in small jumps on the computer screen. When 
the dot takes a double jump the respondent has to react by 
pressing a button. Mean reaction time in seconds, and the 
number of correct responses comprised the two parameters 
of vigilance performance. The test version used in the pre-
sent study differentiates between performances that are sig-
nificantly below average [24]. 
Statistics 
 SPSS 15.0 was used for all statistical analyses. Independ-
ent samples t-tests were used to investigate differences on 
non-categorical outcome variables and participant character-
istics, and a chi-square test was used to investigate if the 
groups differed on the composition of gender. The relation-
ships between PLMD and measures of daytime sleepiness 
were evaluated by hierarchical regression analyses. To con-
trol for possible confounders, age and gender were entered in 
step 1, while AHI and RLS index were entered in step 2. In 
the third and final step PLMD (PLMD vs. non-PLMD) was 
entered. The dependent variables comprised sleepiness 
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measured by the sleep diary, the Epworth Sleepiness Scale, 
and the two vigilance parameters.  
RESULTS 
Patient Characteristics 
 There was a significantly lower proportion of women in 
the PLMD group (7 of 28) compared to the non-PLMD 
group (22 of 36;  = 8.29, df = 64, p < 0.01). The PLMD 
group displayed significantly more wake time after sleep 
onset and had a higher AHI than the non-PLMD group (see 
Table 1). No significant group differences were found on 
age, RLS index, or any of the dependent variables, or on 
frequency of regular (daily or weekly) use of medications (  
= 1.69, df = 64, p = 0.19). There were no differences be-
tween the groups on the use of common medications. 
Subjective Measures of Sleepiness 
 The results from the hierarchical regression analysis 
showed that sleepiness (measured by the ESS) could not be 
explained by the variables (Table 2). All together the vari-
ables accounted for 8% of the variance, and adding PLMD in 
step 3 explained only additionally 0.7% of the variance. The 
same pattern was found measuring sleepiness by the sleep 
diaries; none of the predictors contributed significantly in 
explaining the variance of this variable (see Table 2).  
Objective Measure of Sleepiness 
 The predictors entered in step 1, 2 or 3 of the regression 
analysis did not explain a significant proportion of the vari-
ance in the participants’ mean reaction time (Table 2). Add-
ing PLMD in step 3 explained only 0.1% more of the vari-
ance compared to the confounders in step 1 and 2 (p = 0.66). 
In all, 5% of the total variance was explained.  
 Age and gender were unrelated to the number of correct 
responses. However, the AHI and the RLS index were en-
tered in step 2, contributed to a significant increase in the 
explained variance (p < 0.05). The standardized regression 
coefficient was negative for the AHI implying that an in-
crease on this parameter was associated with a decrease in 
number of correct responses. For the RLS index, the stan-
dardized regression coefficient was positive, thus indicating 
that a positive relationship between the variables existed. 
PLMD explained only 0.1% more of the variance when 
added in step 3 of the analysis (p = 0.83).  
PLMI 
 Replacing PLMD with PLMI as a predictor variable in 
step 3 of the hierarchical regression analyses did not cause 
substantial differences to the results (See Table 3).  
DISCUSSION 
 The aim of the present study was to examine the level of 
sleepiness and daytime functioning in a group of insomnia 
patients with and without co-morbid PLMD. In all, we found 
that the prevalence of PLMD in the current sample was high 
(44%), emphasizing the need for investigating how the dis-
order relates to daytime impairment in insomnia patients [4].  
 In the current study, PLMD was not significantly associ-
ated with increased daytime sleepiness. This finding is 
strengthened by the fact that common confounding variables, 
including age, gender, sleep apnea, and RLS, were statisti-
cally controlled for. The data can be meaningfully inter-
Table 1. Means and Standard Deviations for the Total Sample, the PLMD 
a
 Group and the Non-PLMD Group and t-Values for 
the PLMD Group and the Non-PLMD Group at Baseline 
  Total Sample PLMD Group Non-PLMD Group Group Differences P-Level
 
Variables  Mean (sd) Mean (sd) Mean (sd) t (df)  
Age 61.77 (6.01) 61.71 (5.18) 61.81 (6.65) 0.06 (62) 0.952 
Insomnia duration (in years) 14.97 (11.80) 15.56 (10.98) 14.48 (12.58) -0.35 (58) 0.730 
Epworth Sleepiness Scale 7.80 (4.92) 8.87 (4.74) 6.97 (5.03) -1.55 (62) 0.126 
Sleep diary Sleepiness 2.95 (0.70) 3.00 (0.72) 2.91 (0.70) -0.53 (58) 0.601 
 WASOa (mins) 181.40 (63.53) 180.95 (65.13) 149.37 (60.65) -1.59 (40) 0.119 
 SEb (%) 66.02 (12.24) 61.80 (13.02) 68.62 (11.21) 1.80 (40) 0.079 
Sleep Disorders 
Questionnaire 
RLS-index 2.10 (1.09) 2.18 (1.09) 2.04 (1.10) -0.50 (62) 0.623 
Vigilance test Reaction time (in 
seconds) 
0.56 (0.07) 0.55 (0.07) 0.56 (0.07) 0.72 (61) 0.476 
 No. correct re-
sponses 
98.71 (1.66) 98.71 (1.65) 98.71 (1.69) 0.00 (61) 1.000 
PSG WASOa (mins) 116.41 (82.54) 133.64 (95.14) 83.96 (34.51) 2.04 (47) 0.047 
 SEb (%) 80.97 (10.11) 79.01 (11.26) 84.65 (6.20) -1.91 (47) 0.062 
 AHI-index 10.02 (9.00) 13.29 (11.00) 7.47 (5.98) -2.53 (39.2) 0.016 
a = Wake after sleep onset; b = Sleep efficiency. 
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preted in line with the common observation that PLMD often 
go unnoticed and appear as insomnia [29], demonstrating 
that the daytime consequences of insomnia and PLMD may 
be difficult to separate from each other. This points to the 
necessity of using polysomnographic registrations in the 
assessment and diagnosing of common sleep disorders, espe-
cially since PLMD and insomnia require very different 
treatment approaches. The findings can also be interpreted as 
support for those who question the clinical significance of 
PLMD [4, 12, 18], as a presence of PLMD made no differ-
ences to degree of sleepiness in the current sample.  
 Although some studies have suggested that PLMS may 
be associated with sleep-wake complaints, our findings, 
alongside the majority of studies, point to the contrary. In 
fact, as early as in 1980 Coleman et al. [30] suggested that 
there was no evidence that PLMS actually lead to insomnia, 
and a more recent study on middle-aged and older adults 
showed little or to relationship between PLMS and impaired 
sleep (measures both subjectively and with PSG) [31]. Also, 
a study of younger insomniac patients with and without 
PLMS concluded that PLMS did not appear to be the pri-
mary cause of insomnia in these patients [32]. As such, the 
present study extend on these findings be also showing that 
PLMS have little impact on both nocturnal sleep or daytime 
vigilance. 
 It should also be mentioned that a possible explanation 
for PLMS may be the presence of subclinical sleep disor-
dered breathing (SDB), which also was supported in the pre-
sent study by the higher AHI found in the PLMD group. 
Table 2. Hierarchical Regression Analyses Investigating if PLMD Predicts Subjective Sleepiness and Vigilance After Controlling 
for Third Variables 
 Epworth Sleepiness Scale 
(N=64) 
Sleep Diary - Sleepiness 
(N=60) 
Mean Reaction Time  
(in seconds) (N=63) 
Number of Correct  
Responses (N=63) 
Predictor variables R2 R2  R2 R2  R2 R2  R2 R2  
Step 1 0.032 0.032  0.097 0.097  0.046 0.046  0.004 0.004  
Age   -0.092   -0.242   -0.062   0.157 
Gender   -0.111   -0.131   -0.215   -0.029 
Step 2 0.074 0.042  0.128 0.030  0.053 0.006  0.109 0.105*  
AHI   0.166   0.190   0.072   -0.179 
RLS index   0.083   0.048   -0.049   0.281* 
Step 3 0.081 0.007  0.130 0.002  0.054 0.001  0.110 0.001  
PLMD   0.094   -0.057   -0.034   0.030 
* Significant at the 0.05 level (1-tailed). 
 = standardized regression coefficients. 
 
Table 3. Hierarchical Regression Analyses Investigating if PLMI Predicts Subjective Sleepiness and Vigilance after Controlling 
for Third Variables 
 Epworth Sleepiness Scale 
(N=64) 
Sleep Diary - Sleepiness 
(N=60) 
Mean Reaction Time  
(in seconds) (N=63) 




R2 R2  R2 R2  R2 R2  R2 R2  
Step 1 0.031 0.031  0.109 0.107*  0.067 0.067  0.002 0.002  
Age   -0.099   0.215   0.099   0.150 
Gender   -0.162   -0.223   0.239   -0.073 
Step 2 0.073 0.042  0.144 0.035  0.070 0.003  0.114 0.112*  
AHI   0.202   0.190   0.059   -0.182 
RLS index   0.095   0.014   -0.014   0.297* 
Step 3 0.076 0.003  0.160 0.016  0.072 0.002  0.114 0.000  
PLMD   -0.060   -0.145   0.052   -0.006 
* Significant at the 0.05 level (1-tailed). 
 = standardized regression coefficients. 
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 Nevertheless, we find it somewhat surprising that a night-
time problem like PLMD is not associated with impairment 
in sleepiness, and it remains to be answered why this appar-
ently logical consequence of impaired sleep does not occur. 
One way to explore the lacking relationship would be to look 
closer on the implicit assumption that underlies it, namely 
that a night-time problem like PLMS must cause sleepiness. 
It is for example possible that PLMS and fragmented sleep in 
fact do have measurable consequences, but in the shape of 
autonomous hyperarousal and alertness instead of sleepiness. 
Or alternatively it may be that a perception of having slept 
poorly causes individuals to overcompensate in their daytime 
actions and thereby to perform well on measures of sleepi-
ness. These interpretations are in line with research indicat-
ing that exhaustion and fatigue rather than sleepiness is a 
more likely consequence of sleeplessness [33, 34]. As such, 
it is possible that the PLMD group might have displayed 
impairment on other measures of daytime functioning than 
vigilance and subjective sleepiness.  
 Finally it has been suggested that higher frequency of 
periodic limb movements (PLM) with arousal rather than in 
PLMI may be associated with more disrupted sleep and pos-
sibly also more daytime dysfunction [8]. Although one study 
found no such association with subjective sleepiness [12], 
the consequences of PLM with arousal for daytime function-
ing should be investigated further.  
Study Limitations 
 One limitation of the present study is the limited number 
of patients, possibly causing lack of adequate power. Despite 
a difference on the ESS of 1.9 between the non-PLMD and 
the PLMD, this difference did not reach statistical signifi-
cance. Based upon the pooled standard deviations on this 
measure this equals an effect size (Cohen’s d) of 0.39. Given 
the sample sizes and the effect size as well as standard pa-
rameters for statistical significance ( =.05, two-tailed) this 
equals a statistical power of 0.33. Thus, if the difference be-
tween two groups in the population is in the magnitude of an 
effect size of 0.39 then the probability of finding a statistical 
difference between these two groups given the sample sizes 
in the present study is 33%. Evidently, this statistical power 
is low, but this also pertains to the effect size of 0.39, which 
is between what Cohen defines as low and a moderate. Also, 
the reported ESS scores are comparable to what has been 
reported in previous studies of normal sleepers and PLMD 
patients [22, 35, 36], and the difference in means was com-
parable to what has been observed between severely affected 
apnoeic patients and sleepers with little or no sleep apnea 
[37]. Hence, these findings support the view that the Ep-
worth Sleepiness Scale may not be sensitive enough measure 
of sleepiness in sleep disordered patients [38].  
 It should also be noted that the participants in the present 
study performed no poorer than norm samples on number of 
correct responses on the vigilance test [24]. It is therefore 
possible that a ceiling effect influenced the results, and that a 
more demanding vigilance test would have detected differ-
ences between the groups. Furthermore it may be objected 
that that potential confounding effects of medications cannot 
be ruled out since the participants were not screened for the 
use of drugs that can contribute to the frequency of PLMS 
upon entering the study. However, the finding that the 
groups did not differ in terms of using medications in general 
strengthens the validity of the results. Also, as the sample 
consisted of insomnia patients the result may not be gener-
alizable the general population. Nevertheless, PLMS often 
go unnoticed and subjectively appears as insomnia, and it is 
therefore likely that the participants represented a typical 
group of PLMD patients. Finally, the cross-sectional nature 
of the present study makes it impossible to draw conclusions 
regarding causality. For example, we cannot determine 
whether the PLMD is responsible for the insomnia or not, 
and if treatment would alleviate these symptoms. 
CONCLUSIONS 
 In the present study, patients fulfilling the latest criteria 
for PLMD did not differ from insomnia patients without 
PLMD on neither subjective nor objective indicators of day-
time sleepiness. PLMD did in other words not contribute to 
sleepiness in the insomnia sample, suggesting that daytime 
symptoms of PLMD and insomnia may be difficult to distin-
guish. This underlines the necessity of using polysomno-
graphic registrations in the diagnosing of sleep disorders. 
The findings can also be interpreted in favor of those who 
challenge the clinical significance of PLMD. More studies 
are needed to investigate if the results are generalizable to 
other samples.  
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ABBREVIATIONS  
AHI = Apnea/hypopnea index 
PLMD = Periodic limb movement disorder 
PLMI = Periodic limb movements in sleep index 
PLMS = Periodic limb movements during sleep 
PLM = Periodic limb movements 
RLS = Restless legs syndrome 
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